To provide a comprehensive overview of published case reports for genetic mitochondrial disease (GMD) patients undergoing anesthetic exposures, emphasizing types of procedures and reported complications.
Approach:
Case Report Identification: PubMed was searched for relevant case reports on anesthesia in GMD patients, yielding 148 cases from 123 reports.
Complication Assessment: Complications were categorized into three severity levels: mild, moderate, and severe, based on clinical outcomes.
Statistical Analysis: Descriptive and inferential statistics were used to examine relationships between complications and various factors, acknowledging limitations in data quality.
Key Findings:
GMDs affect approximately 1 in 4000 individuals and exhibit significant genetic and clinical heterogeneity.
Patients with GMD may show hypersensitivity to volatile anesthetic agents, particularly linked to mitochondrial electron transport chain complex I defects.
Anesthetic exposure in GMD patients can lead to a range of complications, including metabolic changes, neurodegenerative disease acceleration, and potential death.
Interpretation:
The review highlights the risks associated with general anesthesia in GMD patients.
Limitations:
The heterogeneity of case reports limits robust statistical analysis.
Insufficient data on long-term outcomes post-anesthesia complicates the assessment of anesthetic impact on disease progression.
Conclusion:
Further research is needed to understand the management of anesthetic procedures in patients with GMD.
